Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
OCS
OCS News & Events
-
Add to Watchlist
Trade OCS Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
OCS News
Oculis Under Investigation After 23.44% Stock Drop Following Trial Failures
4d ago
Globenewswire
Oculis to Present at Clinical Trials Summit 2026 on Neuroprotective Therapy
Jun 11 2026
Newsfilter
Oculis Under Investigation After 23.44% Stock Drop Following Trial Failures
Jun 09 2026
Globenewswire
Oculis Launches Genotype Trial for Dry Eye Disease
Jun 09 2026
Newsfilter
Oculis Highlights Breakthrough Therapies at Goldman Sachs Healthcare Conference
Jun 08 2026
Newsfilter
Oculis Under Investigation for Securities Violations Affecting Shareholder Rights
Jun 08 2026
PRnewswire
Oculis Holding AG Shares Plunge 23% After Trial Failures
Jun 08 2026
PRnewswire
Nan Fung Group Reduces Oculis Stake
Jun 08 2026
NASDAQ.COM
Show More News
OCS Events
No data
OCS Monitor News
Oculis shares plunge after Phase 3 trial failures for OCS-01
Jun 01 2026
OCS Earnings Analysis
No Data
People Also Watch
